196 related articles for article (PubMed ID: 3941165)
1. Contribution of plasma androstenedione to 5 alpha-androstanediol glucuronide in women with idiopathic hirsutism.
Gompel A; Wright F; Kuttenn F; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1986 Feb; 62(2):441-4. PubMed ID: 3941165
[TBL] [Abstract][Full Text] [Related]
2. Urinary 5 alpha-androstane-3 alpha,17 beta-diol radioimmunoassay: a new clinical evaluation.
Wright F; Mowszowicz I; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1978 Oct; 47(4):850-4. PubMed ID: 263329
[TBL] [Abstract][Full Text] [Related]
3. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.
Kirschner MA; Samojlik E; Szmal E
J Clin Endocrinol Metab; 1987 Oct; 65(4):597-601. PubMed ID: 3654909
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
6. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
[TBL] [Abstract][Full Text] [Related]
7. Increased 5 alpha-reductase activity in idiopathic hirsutism.
Serafini P; Lobo RA
Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
[TBL] [Abstract][Full Text] [Related]
8. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
9. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
[TBL] [Abstract][Full Text] [Related]
10. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
11. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
Horton R; Hawks D; Lobo R
J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
[TBL] [Abstract][Full Text] [Related]
12. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
Toscano V; Balducci R; Bianchi P; Guglielmi R; Mangiantini A; Rossi FG; Colonna LM; Sciarra F
Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
[TBL] [Abstract][Full Text] [Related]
13. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
Greep N; Hoopes M; Horton R
J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
[TBL] [Abstract][Full Text] [Related]
15. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
Brochu M; Bélanger A; Tremblay RR
Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
[TBL] [Abstract][Full Text] [Related]
17. [Determination of plasma 5 alpha-androstane-3 alpha, 17 beta-diol in the hirsute woman. A critical study of the biological diagnosis of hyperandrogenism].
Heim J; Massart C
Nouv Presse Med; 1982 Nov; 11(47):3495-9. PubMed ID: 6218480
[TBL] [Abstract][Full Text] [Related]
18. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
Vogt C; Dericks-Tan JS; Kuhl H; Taubert HD
Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
20. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
